In 1983, Congress passed the Orphan Drug Act (“ODA”) as part of an effort to provide market incentives for pharmaceutical manufacturers to produce “orphan drugs,” drugs for diseases that impact less ...
Pharmaceutical Technology on MSN2d
Lundbeck’s amlenetug gains orphan drug status in Japan for MSALundbeck has gained orphan drug designation (ODD) from Japan’s Ministry of Health, Labor and Welfare (MHLW) for amlenetug to ...
Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...
With orphan drugs typically being high value, the potential risk of stock losses should be a top concern for biotechs looking ...
GlobalData on MSN6d
FDA ODD given to Plus Therapeutics’ injectable radiotherapyThe US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Plus Therapeutics’ injectable ...
The FDA granted fast track designation to ATSN-201 for the treatment of X-linked retinoschisis, according to a press release ...
PTC Therapeutics could boost revenue with vatiquinone for Friedreich's ataxia. Find out why PTCT stock is poised for growth ...
Life-saving research in rare cancers would be encouraged under a proposed law aiming to improve access to clinical trials in ...
The European orphan drug market is growing and is already comparable in size and scope to the US market. The European Union ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback